Major cbdMD Stakeholder Executes Eye-Catching Stock Sale

New insider activity at cbdMD ( (YCBD) ) has taken place on December 19, 2025.Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential Significant shareholder Clark R. Crosnoe has unloaded a sizable block of cbdMD stock, selling exactly 550,701 shares in a transaction valued at $1,274,788. This move by a major holder represents a notable shift in ownership and may draw attention from investors tracking insider activity and large-shareholder decisions at cbdMD. Recent Updates on YCBD stock Over the last 24 hours, cbdMD (YCBD) saw trading in its shares halted pending news and later resumed after the company announced a new capital raise and an improved listing status. cbdMD entered into securities purchase agreements with institutional investors for $2.25 million in gross proceeds via Series C convertible preferred stock, which carries a 10% annual dividend and can convert into common shares, bolstering working capital and funding strategic initiatives but also introducing potential dilution. Separately, the company disclosed it has regained full compliance with NYSE American continued listing standards, thanks in part to earlier balance-sheet strengthening actions, including a Series A preferred share conversion and a prior capital raise. While the articles reference negative earnings, cash flow issues, weak technical momentum, and an unfavorable valuation profile as key reasons behind cautious analyst views and subdued price expectations, the compliance milestone and fresh financing are positioned as steps toward stabilizing operations and supporting future growth, which likely drove recent volatility and intraday trading halts/resumptions in the stock rather than a clear directional move in price targets themselves. Spark’s Take on YCBD Stock According to Spark, TipRanks’ AI Analyst, YCBD is a Underperform. The overall stock score is heavily impacted by significant financial challenges, including negative earnings and cash flow issues. Technical analysis indicates weak momentum, and valuation metrics are unfavorable due to the negative P/E ratio. These factors collectively suggest a high-risk investment. To see Spark’s full report on YCBD stock, click here. More about cbdMD YTD Price Performance: -35.67% Average Trading Volume: 13,445,471 Technical Sentiment Signal: Hold Current Market Cap: $20.25M